Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

Cell Bio Human Tech Co., Ltd

셀바이오휴먼텍318160KOSDAQSector: Textiles & Apparel
₩6,6302.07%Market cap ₩61.9BAs of Sep 1, 2026 close · updated once daily
Market cap
₩61.9B
#1019 in KOSDAQ
7.1x
Sector median 7.4x (profitable cos.)
1.09x
Sector median 0.42x
0.0%
Sector median 0.0%
A
Grade A68.9 ptsTop 13% of 2,523 graded stocksMethodology v2.0

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SACurrentBCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band A with a total score of 68.9 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 50 stocks in Textiles & Apparel

1-year closing price

Loading closing price history…
 
Low ₩5,020High ₩10,600
Latest close
Price change by period
1W
2.00%
1M
13.30%
3M
21.60%
1Y
36.80%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

80.1/100
How much debt does it carry relative to equity?
49.9%
Sector median 72.1%
Sector lowhighTop 39.8% in sector
Can it cover what's due within a year?
229.3%
Sector median 172.7%
Sector lowhighTop 33.7% in sector
How much of revenue becomes profit?
18.2%
Sector median 2.2%
Sector lowhighTop 3.1% in sector
How much did it earn on its own capital?
15.4%
Sector median 2.0%
Sector lowhighTop 3.1% in sector

Source filing: annual report (consolidated) — view original

2

Growth momentum

93.6/100
How much did revenue grow in a year?
79.7%
Sector median -1.2%
Sector lowhighTop 3.2% in sector
Did core profits grow in a year?
130.8%
Sector median -15.8%
Sector lowhighTop 9.6% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original

3

Price attractiveness

44.9/100
Is the price expensive relative to earnings?
7.1x
Sector median P/E of profitable peers 7.4x · 39% loss-making
Sector lowhighTop 23.5% in sector
Is the price expensive relative to book value?
1.09x
Sector median 0.42x
Sector lowhighBottom 13.3% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis26.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 26.5% in sector

Dividends & treasury shares

Treasury shares (FY2025)
965,453 shares (10.3% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 5 met · 4 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩8.7B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩1.5B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
8.2% → 16.5%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Not met
₩1.5B vs ₩8.7B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
12.3% → 33.3%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
381.8% → 229.3%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not met
9,260,901 → 9,341,201
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
14.2% → 18.2%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Met
0.53x → 0.97x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original

Grade change history

Jul 23, 2026A

Methodology version change (v2.0 applied)

Jul 15, 2026AVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source
Periodic report filedMay 14, 2026Source

View in the filings calendar →